It is important to note that while BMP‐7 shows promise in preclinical studies, its efficacy and safety as a treatment for glaucoma, including steroid‐induced glaucoma, remain to be conclusively established in human clinical trials. This evidence concerns the gene BMP7 and glaucoma.